Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Real Talk: The Inter-play Between the mTOR, AMPK, and Hexosamine Biosynthetic Pathways in Cell Signaling.

Cork GK, Thompson J, Slawson C.

Front Endocrinol (Lausanne). 2018 Sep 6;9:522. doi: 10.3389/fendo.2018.00522. eCollection 2018. Review.

2.

Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).

Bullen JW, Balsbaugh JL, Chanda D, Shabanowitz J, Hunt DF, Neumann D, Hart GW.

J Biol Chem. 2014 Apr 11;289(15):10592-606. doi: 10.1074/jbc.M113.523068. Epub 2014 Feb 21.

3.

Cross regulation between mTOR signaling and O-GlcNAcylation.

Very N, Steenackers A, Dubuquoy C, Vermuse J, Dubuquoy L, Lefebvre T, El Yazidi-Belkoura I.

J Bioenerg Biomembr. 2018 Jun;50(3):213-222. doi: 10.1007/s10863-018-9747-y. Epub 2018 Mar 9.

PMID:
29524020
4.

Too sweet to resist: Control of immune cell function by O-GlcNAcylation.

de Jesus T, Shukla S, Ramakrishnan P.

Cell Immunol. 2018 Nov;333:85-92. doi: 10.1016/j.cellimm.2018.05.010. Epub 2018 Jun 2.

PMID:
29887419
5.

AMPK regulates histone H2B O-GlcNAcylation.

Xu Q, Yang C, Du Y, Chen Y, Liu H, Deng M, Zhang H, Zhang L, Liu T, Liu Q, Wang L, Lou Z, Pei H.

Nucleic Acids Res. 2014 May;42(9):5594-604. doi: 10.1093/nar/gku236. Epub 2014 Apr 1.

6.

Disruption of O-GlcNAc Cycling in C. elegans Perturbs Nucleotide Sugar Pools and Complex Glycans.

Ghosh SK, Bond MR, Love DC, Ashwell GG, Krause MW, Hanover JA.

Front Endocrinol (Lausanne). 2014 Nov 24;5:197. doi: 10.3389/fendo.2014.00197. eCollection 2014.

7.

Cross-Dysregulation of O-GlcNAcylation and PI3K/AKT/mTOR Axis in Human Chronic Diseases.

Very N, Vercoutter-Edouart AS, Lefebvre T, Hardivillé S, El Yazidi-Belkoura I.

Front Endocrinol (Lausanne). 2018 Oct 9;9:602. doi: 10.3389/fendo.2018.00602. eCollection 2018. Review.

8.

Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer.

Forsythe ME, Love DC, Lazarus BD, Kim EJ, Prinz WA, Ashwell G, Krause MW, Hanover JA.

Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11952-7. Epub 2006 Aug 1.

9.

O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.

Zhang Z, Tan EP, VandenHull NJ, Peterson KR, Slawson C.

Front Endocrinol (Lausanne). 2014 Dec 1;5:206. doi: 10.3389/fendo.2014.00206. eCollection 2014.

10.

The sweet side of AMPK signaling: regulation of GFAT1.

Scott JW, Oakhill JS.

Biochem J. 2017 Mar 23;474(7):1289-1292. doi: 10.1042/BCJ20170006.

PMID:
28336748
11.

Intracellular protein O-GlcNAc modification integrates nutrient status with transcriptional and metabolic regulation.

Nagel AK, Ball LE.

Adv Cancer Res. 2015;126:137-66. doi: 10.1016/bs.acr.2014.12.003. Epub 2015 Feb 7. Review.

PMID:
25727147
12.

mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.

Sodi VL, Khaku S, Krutilina R, Schwab LP, Vocadlo DJ, Seagroves TN, Reginato MJ.

Mol Cancer Res. 2015 May;13(5):923-33. doi: 10.1158/1541-7786.MCR-14-0536. Epub 2015 Jan 30.

13.

mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.

Moloughney JG, Vega-Cotto NM, Liu S, Patel C, Kim PK, Wu CC, Albaciete D, Magaway C, Chang A, Rajput S, Su X, Werlen G, Jacinto E.

J Biol Chem. 2018 Oct 19;293(42):16464-16478. doi: 10.1074/jbc.RA118.003991. Epub 2018 Sep 10.

PMID:
30201609
14.

Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines.

Steenackers A, Olivier-Van Stichelen S, Baldini SF, Dehennaut V, Toillon RA, Le Bourhis X, El Yazidi-Belkoura I, Lefebvre T.

Front Endocrinol (Lausanne). 2016 May 25;7:46. doi: 10.3389/fendo.2016.00046. eCollection 2016.

15.

Nutrient-driven O-GlcNAc cycling - think globally but act locally.

Harwood KR, Hanover JA.

J Cell Sci. 2014 May 1;127(Pt 9):1857-67. doi: 10.1242/jcs.113233. Epub 2014 Apr 24.

16.

Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.

Liu Y, Li X, Yu Y, Shi J, Liang Z, Run X, Li Y, Dai CL, Grundke-Iqbal I, Iqbal K, Liu F, Gong CX.

PLoS One. 2012;7(8):e43724. doi: 10.1371/journal.pone.0043724. Epub 2012 Aug 22.

17.

Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation.

Lucena MC, Carvalho-Cruz P, Donadio JL, Oliveira IA, de Queiroz RM, Marinho-Carvalho MM, Sola-Penna M, de Paula IF, Gondim KC, McComb ME, Costello CE, Whelan SA, Todeschini AR, Dias WB.

J Biol Chem. 2016 Jun 17;291(25):12917-29. doi: 10.1074/jbc.M116.729236. Epub 2016 Apr 18.

18.

O-GlcNAc as an Integrator of Signaling Pathways.

Ong Q, Han W, Yang X.

Front Endocrinol (Lausanne). 2018 Oct 16;9:599. doi: 10.3389/fendo.2018.00599. eCollection 2018. Review.

19.

O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.

Nagel AK, Ball LE.

Amino Acids. 2014 Oct;46(10):2305-16. doi: 10.1007/s00726-014-1827-7. Epub 2014 Aug 31. Review.

20.

Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.

Groussaud D, Khair M, Tollenaere AI, Waast L, Kuo MS, Mangeney M, Martella C, Fardini Y, Coste S, Souidi M, Benit L, Pique C, Issad T.

PLoS Pathog. 2017 Jul 24;13(7):e1006518. doi: 10.1371/journal.ppat.1006518. eCollection 2017 Jul.

Supplemental Content

Support Center